Sudeep Pharma IPO Allotment Expected Today Amid Strong Demand


|

Sudeep Pharma IPO Allotment Expected Today Amid Strong Demand
Sudeep Pharma IPO Allotment Expected Today Amid Strong Demand
Sudeep Pharma's IPO allotment is anticipated today, with shares expected to debut at a 15% premium. Steps to check allotment status included.

The allotment date for the initial public offering (IPO) of Sudeep Pharma Limited is expected to be announced today, 26 November 2025. This follows the IPO's subscription period, which ran from 21 November to 25 November 2025. Following the allotment, the shares are set to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on 28 November 2025.

Sudeep Pharma, a manufacturer of pharmaceutical excipients, has garnered significant interest from investors, leading to an oversubscription of 93.72 times overall. The demand was notably high in the Qualified Institutional Buyer (QIB) segment, which saw a staggering 213.08 times subscription rate. Non-Institutional Investors (NII) participated at 116.72 times, while Retail Individual Investors (RII) subscribed at 15.65 times, indicating strong market confidence in the company’s prospects.

The IPO comprises a fresh issue of 16.02 lakh shares worth ₹95 crore, alongside an offer for sale of 1.35 crore shares amounting to ₹800 crore. The price band for the IPO was set between ₹563 and ₹593 per share. Currently, Sudeep Pharma shares are trading at a grey market premium (GMP) of ₹87, suggesting a likely listing price of around ₹680 per share, which represents a 15% increase from the issue price.

Investors eager to check their allotment status can do so through the official websites of the BSE, NSE, and the IPO registrar, MUFG Intime India. The process is straightforward, requiring users to input their application number or Permanent Account Number (PAN).

Here are the steps to verify the allotment status:

Checking Allotment Status on BSE:

  1. Visit the BSE website at BSE Application Status.
  2. Select 'Equity' in the Issue Type dropdown.
  3. Choose 'Sudeep Pharma Limited' from the Issue Name list.
  4. Enter either your Application Number or PAN.
  5. Confirm you are not a robot and click 'Search.'

Checking Allotment Status on NSE:

  1. Go to the NSE allotment status page at NSE IPO Status.
  2. Select 'Equity and SME IPO bids.'
  3. Choose 'Sudeep Pharma Limited' from the dropdown.
  4. Input your PAN and Application Number.
  5. Click 'Submit' to view your status.

Checking Allotment Status on MUFG Intime:

  1. Visit the MUFG Intime website at MUFG Intime IPO.
  2. Select 'Sudeep Pharma Limited' from the company dropdown.
  3. Choose either PAN, Application Number, DP ID, or Account Number.
  4. Enter the required details.
  5. Click 'Search' for your allotment status.

The company plans to use proceeds from the IPO for capital expenditure, particularly for procuring machinery for its production facility in Gujarat, as well as for general corporate purposes. Sudeep Pharma is well-positioned to benefit from the ongoing growth in India's pharmaceutical and nutrition sectors, bolstered by its extensive product range and established technologies.

As the market awaits the official announcement regarding the allotment and subsequent listing, investors are advised to stay informed about market conditions that could impact share performance on the day of listing.

India Rebuts Pakistan's Criticism of Ram Temple Flag Hoisting
India Rebuts Pakistan's Criticism of Ram Temple Flag Hoisting
India's Ministry of External Affairs criticises Pakistan's comments on the Ram Temple flag hoisting, citing Islamabad's human rights record.
|
Tata Sierra 2025 Launch: A Blend of Luxury and Performance
Tata Sierra 2025 Launch: A Blend of Luxury and Performance
The new Tata Sierra 2025, priced from Rs 11.49 lakh, offers modern design, luxury features, and advanced technology for an exceptional family SUV experience.
|
India's Cabinet Approves Rs 7,200 Crore Scheme for Rare Earth Magnets
India's Cabinet Approves Rs 7,200 Crore Scheme for Rare Earth Magnets
India's government has approved a Rs 7,200 crore initiative to boost domestic production of rare earth permanent magnets, enhancing self-sufficiency.
|
Reliance and L&T Unveil $13.5 Billion Data Centre Investments
Reliance and L&T Unveil $13.5 Billion Data Centre Investments
Reliance Industries and L&T announce significant investments in AI data centres in India, with a focus on Visakhapatnam, totalling $13.5 billion.
|
Apple Challenges Indian Competition Law Over $38 Billion Potential Fine
Apple Challenges Indian Competition Law Over $38 Billion Potential Fine
Apple Inc. contests a new Indian law allowing penalties based on global turnover, fearing a fine of $38 billion. Hearing set for December 3.
|